Literature DB >> 7118298

Growth responses of rat stomach cancer cells to gastro-entero-pancreatic hormones.

O Kobori, M T Vuillot, F Martin.   

Abstract

Various hormones and peptides were added to rat stomach cancer cells growing in vitro in a serum-free medium and the cell number was determined by a spectro-photometric method. Five gastro-entero-pancreatic hormones or related peptides (tetragastrin, glucagon, secretin, cholecystokinin-pancreozymin and cerulein) significantly increased the number of stomach cancer cells from 15% to 310% of the number of control cells cultivated in a serum-free, hormone-free medium. On the other hand, insulin and vasoactive intestinal peptide, and other hormones (thyroxin, epinephrine, hydrocortisone, beta-estradiol, progesterone, testosterone), peptone broth and bovine serum albumin had no significant growth effect. All the active substances belong to the two major families of gastro-entero-pancreatic polypeptide hormones, suggesting the existence of hormone receptors at the surface of stomach cancer cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7118298     DOI: 10.1002/ijc.2910300112

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  17 in total

Review 1.  Hormonal control of gastric and colorectal cancer in man.

Authors:  D L Morris; S A Watson; L G Durrant; J D Harrison
Journal:  Gut       Date:  1989-04       Impact factor: 23.059

2.  The effect of gastrointestinal hormones on the incorporation of tritiated thymidine in the pancreatic adenocarcinoma cell line (WD PaCa).

Authors:  B F Edwards; T W Redding; A V Schally
Journal:  Int J Pancreatol       Date:  1989-09

3.  Serum gastrin concentrations in colorectal cancer patients.

Authors:  R M Charnley; W M Thomas; J Stanley; D L Morris
Journal:  Ann R Coll Surg Engl       Date:  1992-03       Impact factor: 1.891

4.  A comparison of the therapeutic effectiveness of gastrin neutralisation in two human gastric cancer models: relation to endocrine and autocrine/paracrine gastrin mediated growth.

Authors:  S A Watson; T M Morris; A Varro; D Michaeli; A M Smith
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

5.  Gastrin receptors in human gastric scirrhous carcinoma.

Authors:  T Kumamoto
Journal:  Gastroenterol Jpn       Date:  1988-08

6.  Differential changes in calcitonin, somatostatin and gastrin/cholecystokinin-like immunoreactivities in rat thyroid parafollicular cells during ontogeny.

Authors:  L I Larsson
Journal:  Histochemistry       Date:  1985

Review 7.  The production and role of gastrin-17 and gastrin-17-gly in gastrointestinal cancers.

Authors:  Jeffrey Copps; Richard F Murphy; Sándor Lovas
Journal:  Protein Pept Lett       Date:  2009       Impact factor: 1.890

8.  Inhibition of growth of pancreatic carcinomas in animal models by analogs of hypothalamic hormones.

Authors:  T W Redding; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

9.  NK314, a topoisomerase II inhibitor that specifically targets the alpha isoform.

Authors:  Eriko Toyoda; Shigehide Kagaya; Ian G Cowell; Aya Kurosawa; Keiichi Kamoshita; Kiyohiro Nishikawa; Susumu Iiizumi; Hideki Koyama; Caroline A Austin; Noritaka Adachi
Journal:  J Biol Chem       Date:  2008-07-02       Impact factor: 5.157

10.  Effect of endogenous hypergastrinemia on carcinogenesis in the rat esophagus.

Authors:  Y Karaki; K Shimazaki; M Okamoto; H Ookami; M Fujimaki
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.